Literature DB >> 19828339

Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.

Victoria L Woo1, Regina Landesberg, Erik A Imel, Steven R Singer, Andrew L Folpe, Michael J Econs, Taeyun Kim, Lara R Harik, Thomas P Jacobs.   

Abstract

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that results in renal phosphate wasting with hypophosphatemia. In most cases, the underlying cause of TIO is a small mesenchymal neoplasm that is often difficult to detect, resulting in delayed diagnosis. One such neoplasm is the phosphaturic mesenchymal tumor, mixed connective tissue variant (PMTMCT), an unusual entity with unique morphologic and biochemical features. Most of these tumors are found at appendicular sites with only rare cases reported in the jaws. We describe a PMTMCT involving the mandible in a patient with a protracted history of osteomalacia. A review of the current literature is provided with emphasis on the clinical and histologic features, etiopathogenesis, and management of PMTMCT in the setting of TIO.

Entities:  

Mesh:

Year:  2009        PMID: 19828339      PMCID: PMC2783479          DOI: 10.1016/j.tripleo.2009.07.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  45 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  M K Drezner
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Octreotide therapy for tumor-induced osteomalacia.

Authors:  J Seufert; K Ebert; J Müller; J Eulert; C Hendrich; E Werner; N Schuüze; G Schulz; W Kenn; H Richtmann; K D Palitzsch; F Jakob
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

3.  Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.

Authors:  Jorge S Reis-Filho; Maria Emília Paiva; José Manuel Lopes
Journal:  Arch Pathol Lab Med       Date:  2002-10       Impact factor: 5.534

4.  Phosphaturic mesenchymal tumor-induced rickets.

Authors:  M Reyes-Múgica; S L Arnsmeier; P F Backeljauw; J Persing; B Ellis; T O Carpenter
Journal:  Pediatr Dev Pathol       Date:  2000 Jan-Feb

5.  A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia: report of a case.

Authors:  Kyoung-In Yun; Dong-Hoon Kim; Sung-Woon Pyo
Journal:  J Oral Maxillofac Surg       Date:  2009-02       Impact factor: 1.895

6.  The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

Authors:  K E White; K B Jonsson; G Carn; G Hampson; T D Spector; M Mannstadt; B Lorenz-Depiereux; A Miyauchi; I M Yang; O Ljunggren; T Meitinger; T M Strom; H Jüppner; M J Econs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

7.  Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.

Authors:  Y Rhee; J D Lee; K H Shin; H C Lee; K B Huh; S K Lim
Journal:  Clin Endocrinol (Oxf)       Date:  2001-04       Impact factor: 3.478

8.  Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells.

Authors:  K B Jonsson; M Mannstadt; A Miyauchi; I M Yang; G Stein; H Jüppner
Journal:  J Endocrinol       Date:  2001-06       Impact factor: 4.286

9.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

10.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

View more
  22 in total

1.  Evaluation of hypophosphatemia: lessons from patients with genetic disorders.

Authors:  Justine Bacchetta; Isidro B Salusky
Journal:  Am J Kidney Dis       Date:  2011-11-09       Impact factor: 8.860

Review 2.  [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism].

Authors:  J Bacchetta; P Cochat; I B Salusky
Journal:  Arch Pediatr       Date:  2011-04-16       Impact factor: 1.180

Review 3.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 4.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

5.  Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance.

Authors:  Pallavi Suryawanshi; Manish Agarwal; Rahul Dhake; Saral Desai; Bharat Rekhi; Kishor B Reddy; Nirmala Ajit Jambhekar
Journal:  Skeletal Radiol       Date:  2011-05-01       Impact factor: 2.199

6.  Imaging features of phosphaturic mesenchymal tumors.

Authors:  Stephen M Broski; Andrew L Folpe; Doris E Wenger
Journal:  Skeletal Radiol       Date:  2018-07-09       Impact factor: 2.199

7.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

8.  Approach to the hypophosphatemic patient.

Authors:  Erik A Imel; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2012-03       Impact factor: 5.958

Review 9.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

10.  Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.

Authors:  David A Shustik; David Ce Ng; Kesavan Sittampalam
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.